Group 1B: HR+ Breast Cancer; Clinical Trials; Hormone Therapies



Wednesday, June 14
10:00 am – 11:30 am Eastern Time (US/New York)


Click Here to Join Zoom Event

Poster #TPS1119: 

evERA Breast Cancer (BC): Phase III study of giredestrant + everolimus vs exemestane + everolimus in patients (pts) with estrogen receptor-positive, HER2-negative locally advanced or metastatic BC (ER+, HER2– LA/mBC)

Poster #1066:

Clinical activity of camizestrant, a next-generation SERD, versus fulvestrant in patients with a detectable ESR1 mutation: Exploratory analysis of the SERENA-2 phase 2 trial

View Poster PDFs

Mentor: Terri Shipp, M.S.

Terri Shipp shares a passion for science and the education of women affected by breast cancer.  She was personally affected by the disease as a young woman and 12 years later was diagnosed with metastatic breast cancer.  She holds a master’s degree in science in the field of electrical engineering and has actively attended many conferences and seminars on breast cancer.

She graduated in 2022 from Living Beyond Breast Cancer’s (LBBC) Hear My Voice Metastatic Advocacy Program and the National Breast Cancer Coalition’s Project LEAD Program.  She also supports METAvivor’s Michigan #LightUpMBC and the Stage IV Stampede teams.

In 2021, she became an advocate for GRASP and has participated in multiple poster reviews with the authors of various scientific studies. She is excited to be a part of the GRASP program.

Scientist: Matteo Lambertini, M.D., Ph.D.

Matteo Lambertini is associate professor and consultant in medical oncology at the University of Genova – IRCCS Ospedale Policlinico San Martino in Genova (Italy). He is mainly focused in the care of breast cancer patients and is deeply involved in breast cancer research.

Above all, he has a particular expertise in the management of breast cancer in young women, with a specific attention to the fertility and pregnancy-related issues that they have to face after diagnosis.

Thanks to the support of the European Society for Medical Oncology (ESMO), in 2018 he completed his PhD at the Universite Libre de Bruxelles (U.L.B.) in Brussels (Belgium) with a project entitled “Unmet Fertility and Pregnancy-related Issues in Young Breast Cancer Patients”. With this work, he has contributed to improve our understanding of many controversial aspects related to the management of breast cancer in young women specifically focusing on fertility preservation and the possibility to have a pregnancy following treatment completion, with the ultimate goal to further improve the care and quality of life of these young women.

Twitter: @matteolambe